Intrauterine transfusion |
Neonatal exchange transfusion* |
Congenital cell-mediated immunodeficiencies* |
Hodgkin lymphoma (not time-limited; applies to all transfusions during the patient's lifetime) |
Hematopoietic stem cell transplant recipients (autologous or allogeneic)¶ |
Donors of allogeneic hematopoietic stem cells (only applies to the week prior to and during stem cell harvest) |
CAR-T therapy recipients (applies 7 days prior to collection and 3 months post-infusion) |
Purine analog therapy for any diagnosis (eg, fludarabine, cladribine, deoxycoformycin, bendamustine, clofarabine) |
ATG or alemtuzumab therapy for hematologic disease (but not for other diagnoses) |
Recipients of donations from biologic relatives |
Recipients of donations selected on the basis of HLA matching |
Do you want to add Medilib to your home screen?